secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2026-04-23T23:59:59+00:00
Accession:  0001493152-26-018725
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics prices $18M underwritten offering of 18M shares at $1.00 per share
--------------------------------------------------------------------------------

- Offering of 18,000,000 common shares at $1.00 each; gross proceeds ~$18M.
- Underwriters purchase at $0.94/share; net proceeds for working capital and general corporate purposes.
- Anchored by a $15M investment from a fundamental institutional investor and support from a large existing shareholder.
- Closing expected on or about April 24, 2026, subject to customary conditions.
- Canaccord Genuity and BTIG act as joint bookrunners; shelf registration effective March 26, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315226018725/0001493152-26-018725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315226018725/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-018725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer